Calcium oxalate supersaturation increases early after Roux-en-Y gastric bypass

Area of Science:

• Nephrology
• Bariatric Surgery Outcomes
• Urolithiasis Research

Background:

• Calcium oxalate (CaOx) nephrolithiasis is a known complication following Roux-en-Y gastric bypass (RYGB) surgery.
• The precise timing of the elevated risk for CaOx stone formation post-RYGB remains unclear.

Purpose of the Study:

• To determine the temporal relationship between RYGB and the development of CaOx nephrolithiasis risk.
• To investigate changes in urinary parameters contributing to CaOx stone risk after RYGB.

Main Methods:

• Prospective study of 13 morbidly obese adults undergoing RYGB.
• 24-hour urine collections were performed pre-surgery and at 1, 2, 4, and 6 months post-surgery.
• Calcium oxalate relative saturation ratio (CaOx RSR) was calculated using the EQUIL2 model.

Main Results:

• Urinary oxalate excretion significantly increased from baseline to 6 months post-RYGB (median 12.6 to 28.4 mg/24 hr).
• CaOx RSR showed a significant increase starting at 2 months post-RYGB (median 1.4 to 4.9) and continued to rise.
• Reduced urine volume and decreased sodium/potassium excretion were observed, while urinary pH, calcium, magnesium, and citrate remained unchanged.

Conclusions:

• The risk for CaOx nephrolithiasis, indicated by elevated CaOx RSR, emerges as early as 2 months after RYGB.
• The risk escalates gradually in the initial 6 months post-surgery, driven by diminished urine volume and increased oxalate excretion.
• Future interventions focusing on fluid intake and oxalate binding agents are warranted for patients at risk post-RYGB.